Episode 2645
2645: Another Company Delists and It Won't Be the Last!
The SharePickers Podcast with Justin Waite
August 12, 202415m 2s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Welcome to Macro, Micro News for Monday 12th August 2024
A daily podcast covering the Macro & Micro News that's relevant to the UK
To receive my weekly tips email visit www.sharepickers.com/tips
MACRO NEWS
- British employers expect to raise pay by 3% over the coming year, the lowest planned increase in two years
- Potholes causing damage to vehicles is the main concern for the majority of drivers
- Storms and heavy rain all contributed to the highest property insurance payouts for at least seven years
MICRO NEWS
- Argo Blockchain #ARB
- BiVictriX #BVX
- Celadon Pharmaceuticals #CEL
- Destiny Pharma #DEST
To receive my weekly tips visit www.sharepickers.com/tips
PLEASE DO YOUR OWN RESEARCH. NOTHING I WRITE IN THE BLOG SHOULD BE CONSIDERED AS INVESTMENT ADVICE OR AN ENDORSEMENT OF THE COMPANIES MENTIONED. I PERSONALLY HOLD A POSITION IN THIS COMPANY BUT I HAVE A DIVERSIFIED PORTFOLIO AND A STRATEGY THAT MANAGES MY RISK. ANY COMMENTARY SHOULD BE CONSIDERED SUBJECTIVE. THIS SHOULD BE THE STARTING POINT OF YOUR RESEARCH, NOT THE BE-ALL AND END-ALL.
A daily podcast covering the Macro & Micro News that's relevant to the UK
To receive my weekly tips email visit www.sharepickers.com/tips
MACRO NEWS
- British employers expect to raise pay by 3% over the coming year, the lowest planned increase in two years
- Potholes causing damage to vehicles is the main concern for the majority of drivers
- Storms and heavy rain all contributed to the highest property insurance payouts for at least seven years
MICRO NEWS
- Argo Blockchain #ARB
- BiVictriX #BVX
- Celadon Pharmaceuticals #CEL
- Destiny Pharma #DEST
To receive my weekly tips visit www.sharepickers.com/tips
PLEASE DO YOUR OWN RESEARCH. NOTHING I WRITE IN THE BLOG SHOULD BE CONSIDERED AS INVESTMENT ADVICE OR AN ENDORSEMENT OF THE COMPANIES MENTIONED. I PERSONALLY HOLD A POSITION IN THIS COMPANY BUT I HAVE A DIVERSIFIED PORTFOLIO AND A STRATEGY THAT MANAGES MY RISK. ANY COMMENTARY SHOULD BE CONSIDERED SUBJECTIVE. THIS SHOULD BE THE STARTING POINT OF YOUR RESEARCH, NOT THE BE-ALL AND END-ALL.